Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Acuson/Kaiser Permanente

This article was originally published in The Gray Sheet

Executive Summary

Acuson/Kaiser Permanente: Acuson to become two-year, sole-source provider of cardiac ultrasound systems for adult, pediatric, intraoperative and stress echocardiography applications to the 323-hospital health management organization under an Oct. 28 agreement. The deal calls for the HMO to purchase replacement and additional cardiac ultrasound units such as Acuson's Sequoia C256 and Aspen systems. The pact follows an August agreement making Acuson Kaiser's sole-source provider of radiology and vascular ultrasound systems...

You may also be interested in...



UK, US GCP Collaboration Going Strong But Mutual Recognition Not Feasible

While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.

Mallinckrodt’s Generics Business Will File For Bankruptcy

Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”

Milan Will Host The Global Generics & Biosimilars Awards 2020

Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.

UsernamePublicRestriction

Register

MT009043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel